Thomas Simmerer takes over sales at Carl Zeiss Meditec

Succeeds Ulrich Krauss as member of the management board with responsibility for sales

Thomas Simmerer has taken over as a member of the management board responsible for sales at Carl Zeiss Meditec in Germany. He succeeds Ulrich Krauss who has transferred to the management board of Carl Zeiss Vision International, a subsidiary of the Carl Zeiss Group.

‘I am looking forward to my new responsibilities and will maintain and expand the successful sales and service structure at Carl Zeiss Meditec in the respective markets,’ said Simmerer.

Simmerer has extensive experience in medical technology. He was in charge of the Microsurgery strategic business unit in Oberkochen from October 2008. Before joining the medical wing of Carl Zeiss, the mechanical engineer led the top-performing business unit, among others, of Dräger Medical in Lübeck from 1996 to 2008. Prior to this, he was responsible for different sales areas at Heraeus in Hanau.

You may also like

Pharma 5.0

ZEISS and Concept Life Sciences partner to advance automated workflows and AI-powered image analysis in spatial biology

The collaboration focusses on high-throughput imaging, AI-driven data analysis and streamlined integration into lab systems, aiming to improve efficiency and data quality for areas such as drug discovery and cancer research
Research & Development

ZEISS launches initiative to work closely with scientists during experiments

The company is set to partner with leading research institutions such as Max Planck Florida Institute for Neuroscience, where they will be working closely with scientists
Research & Development

Medicines Discovery Catapult and ZEISS set sights on advancing microscopy in drug discovery

Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing the power of advanced microscopy solutions
Manufacturing

Delivering cutting-edge technology

WITec and ZEISS have collaborated to provide a fully integrated instrument, featuring a standard, unmodified vacuum chamber and scanning electron microscope (SEM) column along with a complete confocal Raman microscope and spectrometer
Cell & Gene Therapy

iOrganBio launches with $2m seed round and unveils CellForge, the first AI-powered cell manufacturing platform

Founded by experts in stem cell biology, organoid systems and biomedical engineering, the company aims to revolutionise how human cells are designed and produced for drug discovery and regenerative medicine
Regulatory

NICE backs generic abiraterone for advanced prostate cancer in move set to benefit thousands and save NHS millions

New draft guidance recommends abiraterone for adults with newly diagnosed high-risk metastatic prostate cancer, marking a major shift driven by lower-cost generics and a more dynamic approach to keeping NHS care up to date
Pharma 5.0

Pistoia Alliance launches Phase 3 of CMC Process Ontology to bridge life sciences data gap and accelerate AI adoption

Backed by major pharma companies, the initiative aims to standardise experimental and process data across R&D and manufacturing, enabling automation and AI-ready data throughout the life sciences industry
Subscribe now